Shaklee Corporation
The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+) in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.
The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+), its metabolites, and markers of health in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.
Inclusion Criteria: 1. Males and females, ≥45 to ≤65 years of age 2. BMI ≥18.5 and \<30.0 kg/m2 3. Ambulatory and currently free of injury or other physical impairment that hinders mobility. 4. Willing to use personal smart phone with operating system (Android version 12.0 or newer; iOS version 16 or newer). 5. Willingness to maintain current skin care regimen and avoid any skin-related medical procedures. 6. Willing to adhere to all study procedures, including lifestyle considerations and sign forms providing informed consent to participate in the study and authorization to release relevant…
1000 mg nicotinamide metabolites and plant extracts, taken orally, daily for 60 days
1000 mg maltodextrin, taken orally, daily for 60 days
Arctuva estimate
Verify or correct the compensation shown for this listing.